1. Observation of Bevacizumab intravitreal injection combined with compound trabeculectomy for NVG
- Author
-
Bing Wu, Jian Yang, and Hong-Jun Wei
- Subjects
bevacizumab ,compound trabeculectomy ,neovascular glaucoma ,Ophthalmology ,RE1-994 - Abstract
AIM: To observe the efficacy of Bevacizumab intravitreal injection combined with compound trabeculectomy in the treatment of neovascular glaucoma(NVG). METHODS: The 36 eyes were with bevacizumab intravitreal injection 1wk before surgery, and then were treated with trabeculectomy combined with mitomycin. The visual acuity, intraocular pressure, follicle, anterior chamber, regression of iris neovascularization, the number of anti-glaucoma drugs used and others were observed before injection, 1d after intravitreal injection, 1, 3, 6, and 12mo after surgery, respectively. RESULTS: Total success was achieved in 26 eyes, partial success in 7 eyes and failure in 3 eyes at 1a after surgery. The IOP of 1mo(18.183±6.993mmHg), 3mo(19.586±6.198mmHg), 6mo(18.722±5.263mmHg)and 12mo(19.089±4.133mmHg)after surgery were significantly lower than those before injection(39.997±5.827mmHg)and 1d after injection(39.647±5.690mmHg; all PPP>0.05). The LogMAR visual acuity of 1mo(0.686±0.202), 3mo(0.622±0.157), 6mo(0.631±0.179)and 12mo(0.711±0.177)after surgery were significantly higher than that before injection(0.833±0.207)and 1d after injection(0.806±0.188), and the differences were statistically significant(all PPPt=11.131, PCONCLUSION: The bevacizumab intravitreal injection combined with compound trabeculectomy is effective in the treatment of NVG.
- Published
- 2018
- Full Text
- View/download PDF